Cite
APA Citation
Vermorken, J., Cervantes, A., Morsing, P., Johansson, K., Andersson, T., Roest, N. L., Gullbo, J., & Salazar, R. (n.d.). p-133A randomized, multicenter, open-label controlled phase 2 trial of Foxy-5 as neoadjuvant therapy in patients with WNT5A negative colon cancer. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100094625937.0x000024